维普中文期刊产品整合服务
61篇 您的检索式:作者名="David BJ"
    题名 作者 年代 出处 被引量
1Portal vein thrombosis:Prevalence,patient characteristics and lifetime risk:A population study based on 23796 consecutive autopsies显示文摘瞄准:估计一生在一般人口的门静脉血栓形成(PVT ) 的累积发生。方法:在 1970 和 1982 之间, 23,796 具尸体,在马尔摩城市人口代表 84% 所有在里面医院死亡,被执行,用包括门静脉的检查的一个 standardised 协议。PVT 病人被描述并且在尸体的 PVT 流行,一生的表情累积发生,在高风险的疾病范畴估计了并且以机会比率和 95% CI 表示了。结果:PVT 的人口流行是 1.0% 。有 PVT 28% 的 254 个病人有肝硬化, 23% 主要并且 44% 第二等的肝胆管恶意, 10% 主要腹的传染或煽动性的疾病并且 3% 有 myeloproliferative 混乱。有肝硬化和肝的癌的病人有最高的 PVT 风险,或 17.1 (95% CI 11.1-26.4 ) 。在 14% ,没有原因被发现;仅仅,少数他们开发了 portal-hypertension-related 复杂并发症。结论:在这基于人口的研究, PVT 比由以前的临床的系列显示被发现更普通。显著地,在肝硬化和肝的癌的过量风险应该在指导干预的未来的研究可能为被考虑的这些病人保证增加的了解。Mats gren David Bergqvist Martin Bjrck Stefan Acosta Henry Eriksson Nils H Sternby 2006World Journal of Gastroenterology2006,12,13:66
2Validation of Fujinon intelligent chromoendoscopy with high definition endoscopes in colonoscopy显示文摘AIM:To validate high definition endoscopes with Fujinon intelligent chromoendoscopy(FICE) in colonoscopy.METHODS:The image quality of normal white light endoscopy(WLE),that of the 10 available FICE filters and that of a gold standard(0.2% indigo carmine dye) were compared.RESULTS:FICE-filter 4 [red,green,and blue(RGB) wavelengths of 520,500,and 405 nm,respectively] provided the best images for evaluating the vascular pattern compared to white light.The mucosal surface was best assessed using filter 4.However,the views obtained were not rated significantly better than those observed with white light.The 'gold standard',indigo carmine(IC) dye,was found to be superior to both white light and filter 4.Filter 6(RGB wavelengths of 580,520,and 460 nm,respectively) allowed for exploration of the IC-stained mucosa.When assessing mucosal polyps,both FICE with magnification,and magnification following dye spraying were superior to the same techniques without magnification and to white light imaging.In the presence of suboptimal bowel preparation,observation with the FICE mode was possible,and endoscopists considered it to be superior to observation with white light.CONCLUSION:FICE-filter 4 with magnification improves the image quality of the colonic vascular patterns obtained with WLE.Adolfo Parra-Blanco Alejandro Jiménez Bjrn Rembacken Nicolás González David Nicolás-Pérez Antonio Z Gimeno-García Marta Carrillo-Palau Takahisa Matsuda Enrique Quintero 2009World Journal of Gastroenterology2009,15,42:12
3钠-葡萄糖共转运蛋白-2抑制剂或胰高血糖素样肽-1受体激动剂治疗成人2型糖尿病:临床实践指南显示文摘临床问题对于存在不同心血管风险及肾脏结局的2型糖尿病患者,在原有生活方式干预和/或其他降糖药物的基础上加用钠-葡萄糖共转运蛋白2(SGLT-2)抑制剂和胰高血糖素样肽1(GLP-1)受体激动剂的获益及风险是什么?现行做法几十年来,2型糖尿病的治疗决策都以控制血糖为主导。SGLT-2抑制剂和GLP-1受体激动剂在传统观念中常被用于二甲双胍治疗后血糖仍控制不佳的患者。目前这一现状已经发生了改变,这得益于多项临床研究结果。研究显示SGLT-2抑制剂和GLP-1受体激动剂拥有独立于药物降糖作用之外的对于动脉粥样硬化性心血管病(CVD)和慢性肾脏病(CKD)的获益。建议本指南阐述了针对不同风险分层的成人2型糖尿病患者使用SGLT-2抑制剂或GLP-1受体激动剂的建议。•伴有3种或更少的心血管风险因素且不存在CVD或CKD:不建议启动SGLT-2抑制剂或GLP-1受体激动剂治疗。(推荐等级:弱)•伴有3种以上心血管风险因素且不存在CVD或CKD:建议启动SGLT-2抑制剂治疗,不建议启动GLP-1受体激动剂治疗。(推荐等级:弱)•已经存在CVD或CKD:建议启动SGLT-2抑制剂治疗和GLP-1受体激动剂治疗。(推荐等级:弱)•已经存在CVD和CKD:建议启动SGLT-2抑制剂治疗(推荐等级:强)和GLP-1受体激动剂治疗。(推荐等级:弱)•对于那些想要进一步降低CVD和CKD结局风险的患者:推荐优先启用SGLT-2抑制剂治疗而非GLP-1受体激动剂治疗。(推荐等级:弱)这项指南是如何制订的一个由患者、临床医生和方法学家共同组成的国际小组提出了这些推荐意见。这些推荐意见基于可信度较高的指南的标准,并使用GRADE分级方法进行评估。该小组采用了息者个体化的观点。证据一项关于获益与风险的系统综述和网络meta分析(764项随机对照研究,包括421346例参与者)发现SGLT-2抑制剂和GLP-1受体激动剂可以降低总体死亡率、心肌梗死发生率、终末期肾病或肾衰竭的发生率(中等至高等质量的证据)。在不同的亚组中这些药物对卒中、因心力衰竭所致住院和其他主要不良事件有不同的影响。药物绝对获益的程度因患者个体风险的不同有很大的差异。(例如,对于接受了超过5年药物治疗的1000例患者,在最低风险人群中死亡人数减少了5人,在最高风险人群中死亡人数减少了48人)。一项关于预后的综述确认了14种风险预测模型,其中一种(RECODe)在证据总结中报告了大部分基线风险评估数据,小组利用该模型以支持风险分层的建议。考虑到患者的价值观及个体差异,指南推荐的支撑证据包括一项对已发表论文的系统综述、一项患者焦点小组研究、一项临床问题总结,以及一项指南调查。指南解读我们依据不同的CVD和CKD风险水平,综合考虑获益、风险和其他因素的平衡,以及每一个风险组别的实际问题,来对推荐意见进行分层。本指南强烈建议CVD和CKD患者使用SGLT-2抑制剂治疗,这说明专家组认为其具有显著的获益。而对于其他成人2型糖尿病患者,推荐等级较弱,这说明专家组想要在获益、风险及治疗花费上取得一个更好的平衡。临床医生通过该指南可以使用可靠的风险计算模型,如RECODe,来明确其患者的个体心血管和肾脏疾病风险。医患交互式总结临床证据和制订决策有助于患者知晓治疗选择,包括进行共同决策。2型糖尿病人群(全球患病率不断增长1-2)正面临着不断增加的心血管疾病、肾脏病和其他并发症的风险3。数十年来,2型糖尿病的管理始终以控制血糖及糖化血红蛋白(HbA1c)为治疗目标4-5,但是,最近的高质量随机对照研究已经对这种以血糖为中心的治疗模式发起了挑战。研究结果显示,强化血糖控制未必会降低大血管不良事件,它还可能带来不利影响监管机构现在要求新型糖尿病药物必须证明其具有心血管和肾脏获益才能获得批准。对两类新药--钠-葡萄糖共转运蛋白2(SGLT-2)抑制剂和胰高血糖素样肽1(GLP-1)受体激动剂(见框图1)的临床试验结果显示,在现有治疗方案(常规治疗)之上加用这些药物,对死亡、心肌梗死、卒中、心力衰竭和肾脏的结局(如进展为终末期肾病)都有获益8-12。Sheyu Li Per Olav Vandvik Lyubov Lytvyn Gordon H Guyatt Suetonia C Palmer Rene Rodriguez-Gutierrez Farid Foroutan Thomas Agoritsas Reed A C Siemieniuk Michael Walsh Lawrie Frere David J Tunnicliffe Evi V Nagler Veena Manja Bjφrn Olav Asvold Vivekanand Jha Mieke Vermandere Karim Gariani Qian Zhao Yan Ren Emma Jane Cartwright Patrick Gee Alan Wickes Linda Fems Robin Wright Ling Li Qiukui Hao Reem A Mustafa 郭鹤鸣(译) 2021英国医学杂志中文版2021,24,9:7
4Clinical and molecular genetic features of ARC syndrome显示文摘Paul Gissen Louise Tee Colin A. Johnson Emmanuelle Genin Almuth Caliebe David Chitayat Carol Clericuzio Jonas Denecke Maja Rocco Bj?rn Fischler David FitzPatrick Angeles García-Cazorla Delphine Guyot Sebastien Jacquemont Sibylle Koletzko Bruno Leheup Hann 2006Human Genetics2006,,3:2
5Is the intermediate syndrome in organophosphate poisoning the result of insufficient oxime therapy显示文摘Benson BJ David T Matilda M 1992Toxicol Clin Toxicol1992,30,:1
6Laparosopic cholecystectomy : are patients with biliary pancreatitas at increased operative risk? 显示文摘Ammor BJ Davides D Vezakis A 2003Surg Endosc2003,17,5:1
7Intraoperative cholangiography during laparoscopic cholecystectomy 显示文摘Vezakis A Davides D Ammori BJ 2000Surg Endosc2000,14,12:1
8Clinical Implications for the Management of Acute Thromboembolic Occlusion of the Superior Mesenteric Artery: Autopsy Findings in 213 Patients显示文摘Stefan Acosta Mats ?gren Nils-Herman Sternby David Bergqvist Martin Bj?rck 2005Annals of Surgery2005,,3:1
9Changes in left ventricular mass and volumes in patients receiving ACEI therapy for lift ventricular dysfunction after Q-wave MI显示文摘Robert EF David BJ Francesco B 1998Am Heart J1998,136,:1
10Laparoscopic cholecystectomy:are patients with biliary panereatitis at increased operative fisk显示文摘Ammori BJ Davides D Vezakis A 2003Surg Endose2003,17,5:1
11Pathophysiologic and Therapeutic Importance of Tissue ACE: A Consensus Report显示文摘Victor J. Dzau Kenneth Bernstein David Celermajer Jerome Cohen Bj?rn Dahl?f John Deanfield Javier Diez Helmut Drexler Roberto Ferrari Wiek van Gilst Lennart Hansson Burkhard Hornig Ahsan Husain Colin Johnston Harold Lazar Eva Lonn Thomas Lüscher John Manc 2002Cardiovascular Drugs and Therapy2002,,2:1
12Five-Aminosalicylic Acid: An Update for the Reappraisal of an Old Drug显示文摘Cristiana Perrotta Paolo Pellegrino Eliana Moroni Clara De Palma Davide Cervia Piergiorgio Danelli Emilio Clementi Bj?rn Moum 2015Gastroenterology Research and Practice2015,,:1
13Laparoscopic cholecystectomy:are patients with biliary pancreatitis at increased operative risk?显示文摘Ammori BJ Davides D Vezakis A 2003Surg Endosc2003,17,5:1
14Intraoperative cholangiography during laparoscopic cholecystectomy显示文摘Vezakis A Davides D Ammori BJ 2000Surg Endosc2000,14,12:1
15Finite Element Simulation of Slotted Tube (stem) With the Presence of Plaque and Artery by Balloon Expansion 显示文摘David Chua SN Mac Donald BJ Hashmi MSJ 2004Journal of Materials Processing Technology2004,,:1
16laparoscopie cholecystectomy :are patients with biliary panereatitis at increased operative risk? 显示文摘Ammori BJ Davides D Vezakis A 2003Surg Endosc2003,17,5:1
17Increased Expression of Visfatin in Macrophages of Human Unstable Carotid and Coronary Atherosclerosis: Possible Role in Inflammation and Plaque Destabilization显示文摘Tuva B. Dahl Arne Yndestad Mona Skjelland Erik ?ie Arve Dahl Annika Michelsen Jan K. Dam?s Siv H. Tunheim Thor Ueland Camilla Smith Bj?rn Bendz Serena Tonstad Lars Gullestad Stig S. Fr?land Kirsten Krohg-S?rensen David Russell P?l Aukrust Bente Halvorsen 2007Circulation2007,,8:1
18Laparoscopic treatment of Mirizzi syndrome显示文摘 Davides D Biras K Ammori BJ Larvin M Mcmahon MJ 2000Surgical Laparoscopy Endoscopy & Percutaneous Techniques2000,10,1:1
19Intraoperative cholangiography during Laparoscopic cholecystectomy 显示文摘A Vezakis D Davides BJ Ammori 2000Surg Endosc2000,14,:1
20Anterior cervical osteophytes resulting severe dysphagia and aspiration: two case reports and literature review 显示文摘Kos MP van Royen BJ David EF 2009J Laryngol Otol2009,123,10:1
返回顶部 每页显示:
共4页 首页 上一页 第1页 下一页 末页 /4 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费